{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:40:17Z","timestamp":1790260817881,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ekir.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:37:16Z","timestamp":1522294636000},"page":"916-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features"],"prefix":"10.1016","volume":"3","author":[{"given":"Alexandra","family":"Cambier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rabant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Peuchmaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Deschenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Couchoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2018.03.013_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.ndt.a027821","volume":"13","author":"Coppo","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.03.013_bib2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1681\/ASN.2012010063","article-title":"Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria","volume":"23","author":"Guti\u00e9rrez","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib4","doi-asserted-by":"crossref","first-page":"e0150885","DOI":"10.1371\/journal.pone.0150885","article-title":"Proteinuria during follow-up period and long-term renal survival of childhood IgA nephropathy","volume":"11","author":"Kamei","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2018.03.013_bib5","first-page":"123","article-title":"IgA nephropathy","volume":"76","author":"McCoy","year":"1974","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2018.03.013_bib6","first-page":"118","article-title":"Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese","volume":"28","author":"Kusumoto","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(95)70027-7","article-title":"IgA nephropathy: long-term prognosis for pediatric patients","volume":"127","author":"Wyatt","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ekir.2018.03.013_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-006-0303-3","article-title":"Renal survival in pediatric patients with IgA nephropathy","volume":"22","author":"Hastings","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00467-006-0163-x","article-title":"Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study","volume":"21","author":"Ronkainen","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-012-2294-6","article-title":"Spontaneous remission in children with IgA nephropathy","volume":"28","author":"Shima","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1600141","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"374","author":"Robert","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.03.013_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00467-016-3373-x","article-title":"Measuring and estimating glomerular filtration rate in children","volume":"32","author":"Pottel","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1373\/clinchem.2008.122218","article-title":"Estimating equations for glomerular filtration rate in children: laboratory considerations","volume":"55","author":"Miller","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2018.03.013_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D'Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.03.013_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1681\/ASN.V101101","article-title":"A\u00a0controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group","volume":"10","author":"Yoshikawa","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/kisup.2012.12","article-title":"Abstract","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ekir.2018.03.013_bib19","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.03.013_bib20","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","article-title":"IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria","volume":"18","author":"Coppo","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00852535","article-title":"Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone","volume":"7","author":"Waldo","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000188848","article-title":"Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study","volume":"72","author":"Kobayashi","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2018.03.013_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10157-015-1129-8","article-title":"Epidemiological survey and clinical investigation of pediatric IgA nephropathy","volume":"20","author":"Shibano","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib24","first-page":"121","article-title":"Primary IgA nephropathies in children: prognosis and treatment","volume":"22","author":"Niaudet","year":"1993","journal-title":"Adv Nephrol Necker Hosp"},{"key":"10.1016\/j.ekir.2018.03.013_bib25","first-page":"2054","article-title":"Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy","volume":"10","author":"Roccatello","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.03.013_bib26","first-page":"789","article-title":"Rapidly progressive IgA nephropathy","volume":"142","author":"Welch","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ekir.2018.03.013_bib27","first-page":"441","article-title":"Does methylprednisolone pulse therapy deteriorate the course of rapidly progressive IgA nephropathy?","volume":"143","author":"Itami","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ekir.2018.03.013_bib28","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1681\/ASN.2014070697","article-title":"Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study","volume":"26","author":"Tesar","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-6386(12)80031-X","article-title":"Angiotensin II local hyperreactivity in the progression of IgA nephropathy","volume":"21","author":"Coppo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.03.013_bib30","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2215\/CJN.11521210","article-title":"Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification","volume":"6","author":"Shi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00467-016-3469-3","article-title":"Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort","volume":"32","author":"Coppo","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2215\/CJN.01120905","article-title":"Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial","volume":"1","author":"Yoshikawa","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.03.013_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies","volume":"79","author":"El Karoui","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib34","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/ndt\/gfq812","article-title":"Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort","volume":"26","author":"Bellur","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.03.013_bib35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ki.2015.116","article-title":"Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis","volume":"88","author":"Kuppe","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.2009.02135.x","article-title":"Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes","volume":"39","author":"Wang","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ekir.2018.03.013_bib37","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.25011\/cim.v32i1.5083","article-title":"Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways","volume":"32","author":"Ye","year":"2009","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ekir.2018.03.013_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ki.2009.473","article-title":"Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes","volume":"77","author":"Coppo","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ki.2010.43","article-title":"The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults","volume":"77","author":"Coppo","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.03.013_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5414\/CNP71625","article-title":"Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy","volume":"71","author":"Jiang","year":"2009","journal-title":"Clin Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918300688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918300688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T09:37:37Z","timestamp":1660729057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024918300688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2468024918300688"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2018.03.013","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}